BCM
CVET

Bayesian Capital Management’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bayesian Capital Management’s Portfolio CVET Stock Details CVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-21,400
Closed -$444K – 1106
2022
Q2 		$444K Buy
+21,400
New +$381K 0.08% 366
2020
Q3 		– Sell
-14,385
Closed -$257K – 749
2020
Q2 		$257K Sell
14,385
-25,200
-64% -$331K 0.06% 388
2020
Q1 		$322K Buy
+39,585
New +$452K 0.07% 425

Other funds holding CVET

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bayesian Capital Management's CVET Position: Q3 2022 in Review

Bayesian Capital Management sold out of Covetrus, Inc. Common Stock (CVET) in Q3 2022, closing a stake of 21,400 shares — an estimated $444K sold.

Bayesian Capital Management first reported a position in CVET in Q1 2020 and held it in 3 quarters. The position peaked at $444K in Q2 2022. 250 funds tracked by Wall St. Rank hold CVET as of Q3 2022.

  • Bayesian Capital Management reported no remaining Covetrus, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Bayesian Capital Management sold 21,400 Covetrus, Inc. Common Stock shares in Q3 2022, an estimated $444K.
  • Bayesian Capital Management first reported a position in Covetrus, Inc. Common Stock in Q1 2020 and held it in 3 quarters.
  • Bayesian Capital Management's Covetrus, Inc. Common Stock position peaked at $444K in Q2 2022.
  • 250 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q3 2022.

Based on Bayesian Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.